Diversity, Equity and Inclusion:
Commitment to DE&I
We are committed to a fair, equitable and non-discriminatory workplace where there are meaningful platforms for dialogue and progress. This starts from the top – our managers are expected to act as role models for our values every day. We are committed to creating a gender-balanced and inclusive workplace, and to see change, we have to start with our people.
Takeda’s Center for Health Equity and Patient Affairs
Talent Acquisition, Development & Retention
Takeda has and will continue to strengthen our talent acquisition processes with an enhanced focus on diversity, equity and inclusion. There are a number of initiatives underway:
• Implementation of Bias reducing tool (in final stages with technology vendors)
• Roll out of DE&I and Behavioral Based interview training
• Implementation enterprise-wide Candidate Relationship Management (CRM) tool connected with Applicant Tracking System (ATS) to create inclusive talent communities
Merck Accelerates Climate Goals; Announces Carbon Neutrality in Operations by 2025
In April 2021, Merck announced ambitious goals to achieve carbon neutrality across its operations by 2025 (Scopes 1 & 2 emissions) and a 30% reduction in its value chain emissions by 2030 (Scope 3 emissions).1
These goals are aligned with science and build on Merck’s long-standing focus on preventing the worst impacts of climate change and supporting the global effort to achieve the Paris Agreement goals by reducing demand for energy and minimizing greenhouse gas (GHG) emissions.
Our Commitment to Environmental Sustainability for a Brighter Future
By 2025, we commit to reducing GHG emissions in our operations by 40% from FY2016 levels. We will cut Scope 3 emissions by 15% based on FY2018 levels.
By 2024, we will help 67% of our suppliers to establish their own science-based emissions targets.
We are committed to working to achieve net-zero GHG emissions in our operations before 2035. By 2040, we are committed to reaching net-zero for our entire value chain, including currently estimated scope 3 GHG emissions.
Sustainability by Design
Our Sustainability by Design program aims to minimize our environmental footprint by incorporating sustainability principles during every stage of product development. The activities involve R&D, Drug Products & Processing and Packaging and Devices. They are designed to minimize the environmental impact of all future products throughout their life cycle.